Demonstrates controlled drug release using an electro-assisted magnesium battery, suggesting advanced therapy potential.
Although stimulus-responsive drug delivery systems allow for precise drug release, electro-assisted delivery methods are seldom incorporated into transdermal platforms, highlighting a major research gap. In this work, we developed a self-powered, controllable drug delivery platform using a conductive gelatin methacryloyl-polyacrylamide-polypyrrole hydrogel (GPP) as the cathode in a magnesium battery. The GPP hydrogel was synthesized via UV cross-linking and in situ polymerization, exhibiting a compact porous structure, enhanced mechanical strength (fracture strain: 234%), stable electrochemical performance, and excellent cytocompatibility. It also functioned as a sensitive strain sensor (gauge factor: 1.14). Drug release was precisely tuned by electrical stimulation, increasing from 0.2 mg/g at 0 V to nearly 1.6 mg/g at −0.8 V within 180 min. The integrated Mg-GPP battery powered drug delivery effectively, achieving a 5-fold enhancement over passive diffusion. This system provides a promising strategy for advanced personalized transdermal therapy with combined electrically controlled release and motion sensing capability.
No takes yet. Share an insight, caveat, or question.
Mu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: